Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

A Multicenter, non-comparative trial on the contraceptive efficacy, safety, and tolerability of LPRI-424 (dienogest 2 mg/ethinyl estradiol 0.02 mg) during 13 cycles
New Birth Control Pill Study
Sponsor:Chemo Research S.L
Enrolling:Female Patients Only
Study Length:13 Months
Clinic Visits:9
Age Range:Between 18 and 35 years old
IRB Number:AAAS7395
U.S. Government ID:NCT03945513
Contact: Molly Morgan: (212) 305-0947 / mjm2331@cumc.columbia.edu
Additional Study Information:

If you are a woman between the ages of 18 and 35, are pre-menopausal, sexually active and do NOT wish to become pregnant, you are invited to see if you may qualify for a research study. The purpose of this research study is to test the effectiveness of an investigational oral birth control pill. If you qualify, you will receive investigational study medication, study-related medical exams, and laboratory services at no charge. You may also be reimbursed for time, travel, and other expenses.

Do You Qualify?
Are you between 18 and 35 years of age?YesNo
Are you currently sexually active with a male partner?YesNo
Do you have a regular menstrual cycle?YesNo
Submit
Cancel
Investigator
Carolyn Westhoff, MD
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Molly Morgan
Email: mjm2331@cumc.columbia.edu
Phone: (212) 305-0947